• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型遗传性出血性毛细血管扩张症患者早期发生肺动脉高压,随后发展为弥漫性肺动静脉畸形。

Early-life pulmonary arterial hypertension with subsequent development of diffuse pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia type 1.

作者信息

Mache C J, Gamillscheg A, Popper H H, Haworth S G

机构信息

Department of Pediatrics, Medical University Graz, Auenbruggerplatz 30, A-8036 Graz, Austria.

出版信息

Thorax. 2008 Jan;63(1):85-6. doi: 10.1136/thx.2007.076109.

DOI:10.1136/thx.2007.076109
PMID:18156574
Abstract

The case history is presented of a male infant who was thought to have idiopathic pulmonary arterial hypertension (PAH) at 3 months of age. Subsequently the PAH decreased unexpectedly and diffuse pulmonary arteriovenous malformations (PAVMs) were seen at 6.9 years of age for the first time. Hereditary haemorrhagic telangiectasia type 1 (HHT1) related to an endoglin mutation was diagnosed. At 10.3 years of age a lung biopsy showed diffuse PAVMs as well as pulmonary arteriopathy with medial hypertrophy. This is the first case of HHT1 presenting with PAH at such a young age. The subsequent decrease in pulmonary arterial pressure (PAP) was probably caused by the development of PAVMs. In the presence of PAVMs, measurement of the PAP may underestimate the extent of PAH-related vasculopathy.

摘要

本文介绍了一名男婴的病例史。该男婴在3个月大时被认为患有特发性肺动脉高压(PAH)。随后,PAH意外下降,在6.9岁时首次发现弥漫性肺动静脉畸形(PAVM)。诊断为与内皮素基因突变相关的1型遗传性出血性毛细血管扩张症(HHT1)。在10.3岁时,肺活检显示弥漫性PAVM以及伴有中层肥厚的肺血管病。这是首例在如此年幼时出现PAH的HHT1病例。随后肺动脉压(PAP)的下降可能是由PAVM的发展引起的。在存在PAVM的情况下,PAP的测量可能会低估PAH相关血管病变的程度。

相似文献

1
Early-life pulmonary arterial hypertension with subsequent development of diffuse pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia type 1.1型遗传性出血性毛细血管扩张症患者早期发生肺动脉高压,随后发展为弥漫性肺动静脉畸形。
Thorax. 2008 Jan;63(1):85-6. doi: 10.1136/thx.2007.076109.
2
Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).遗传性出血性毛细血管扩张症(伦杜-奥斯勒病)的肺血管表现
Respiration. 2007;74(4):361-78. doi: 10.1159/000103205.
3
Lobar embolization for treatment of diffuse pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a case report.肺叶栓塞治疗遗传性出血性毛细血管扩张症弥漫性肺动静脉畸形:一例报告。
J Vasc Interv Radiol. 2010 Jul;21(7):1105-8. doi: 10.1016/j.jvir.2010.02.040. Epub 2010 May 26.
4
Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia.缺血性中风/脑脓肿风险的主要决定因素与遗传性出血性毛细血管扩张症中肺动静脉畸形的严重程度无关。
Thorax. 2008 Mar;63(3):259-66. doi: 10.1136/thx.2007.087452. Epub 2007 Nov 2.
5
Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia.伴有ALK1突变和遗传性出血性毛细血管扩张症的年轻人肺动脉高压的临床特征
Arch Dis Child. 2009 Jul;94(7):506-11. doi: 10.1136/adc.2007.133082. Epub 2009 Apr 8.
6
Pulmonary arteriovenous malformations, hereditary hemorrhagic telangiectasia, and brain abscess.肺动静脉畸形、遗传性出血性毛细血管扩张症和脑脓肿。
Respiration. 2006;73(4):553-7. doi: 10.1159/000087150. Epub 2005 Jul 21.
7
Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH.遗传性出血性毛细血管扩张症和严重肺动脉高压导致的肺动静脉畸形破裂致死。
Eur Respir Rev. 2009 Mar;18(111):42-6. doi: 10.1183/09059180.00011113.
8
Images in vascular medicine. Endovascular coil embolization of pulmonary AV malformations in a patient with hereditary hemorrhagic telangiectasia.血管医学影像。遗传性出血性毛细血管扩张症患者肺动静脉畸形的血管内弹簧圈栓塞术。
Vasc Med. 2009 May;14(2):167-8. doi: 10.1177/1358863X08101642.
9
[Pulmonary arterial hypertension in patients with hereditary hemorrhagic telangiectasia (Osler-Rendu disease)].遗传性出血性毛细血管扩张症(奥斯勒-伦杜病)患者的肺动脉高压
Ter Arkh. 1986;58(4):81-3.
10
An association of migraine with hereditary haemorrhagic telangiectasia independently of pulmonary right-to-left shunts.偏头痛与遗传性出血性毛细血管扩张症之间的关联,与肺右向左分流无关。
Cephalalgia. 2009 Jan;29(1):76-81. doi: 10.1111/j.1468-2982.2008.01703.x. Epub 2008 Sep 2.

引用本文的文献

1
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.定义被报道可导致肺动脉高压的基因的临床有效性。
Genet Med. 2023 Nov;25(11):100925. doi: 10.1016/j.gim.2023.100925. Epub 2023 Jul 5.
2
Cardiac and Hemodynamic Manifestations of Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症的心脏和血流动力学表现
Int J Angiol. 2022 Jul 9;31(2):75-82. doi: 10.1055/s-0042-1745842. eCollection 2022 Jun.
3
New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis.
肺动脉高压的新突变和发病机制:疾病发病机制中的进展和困惑。
Circ Res. 2022 Apr 29;130(9):1365-1381. doi: 10.1161/CIRCRESAHA.122.320084. Epub 2022 Apr 28.
4
Metabolism in Pulmonary Hypertension.肺动脉高压中的代谢
Annu Rev Physiol. 2021 Feb 10;83:551-576. doi: 10.1146/annurev-physiol-031620-123956.
5
A novel BMPR2 mutation in a patient with heritable pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia: A case report.一名患有遗传性肺动脉高压并疑似遗传性出血性毛细血管扩张症患者的新型骨形态发生蛋白受体2(BMPR2)突变:病例报告
Medicine (Baltimore). 2020 Jul 31;99(31):e21342. doi: 10.1097/MD.0000000000021342.
6
Role of BRCA1-associated protein (BRAP) variant in childhood pulmonary arterial hypertension.BRCA1 相关蛋白(BRAP)变异在儿童肺动脉高压中的作用。
PLoS One. 2019 Jan 31;14(1):e0211450. doi: 10.1371/journal.pone.0211450. eCollection 2019.
7
Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia.肺动脉高压与遗传性出血性毛细血管扩张症。
Int J Mol Sci. 2018 Oct 17;19(10):3203. doi: 10.3390/ijms19103203.
8
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.肺动脉高压:关于已确定和新出现的分子遗传缺陷的当前观点
Hum Mutat. 2015 Dec;36(12):1113-27. doi: 10.1002/humu.22904. Epub 2015 Oct 12.
9
Pulmonary hypertension in hereditary haemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中的肺动脉高压
World J Cardiol. 2015 May 26;7(5):230-7. doi: 10.4330/wjc.v7.i5.230.
10
Endoglin: a critical mediator of cardiovascular health.内皮糖蛋白:心血管健康的关键介质。
Vasc Health Risk Manag. 2013;9:195-206. doi: 10.2147/VHRM.S29144. Epub 2013 May 6.